Feb 20, 2026· Comment from Alliance for Pharmacy Compounding and the National Community Pharmacists Association· FDA-2025-N-6743-1912
Comment from the Alliance for Pharmacy Compounding and the National Community Pharmacists Association
FDANonrulemakingFDA-2025-N-6743
Food and Drug Administration Expert Panel on Testosterone Replacement Therapy for Men; Request for Information
RIN
—
Last modified
Jan 14, 2026
Comment window
closed 169d ago
National Community Pharmacists Association filings
1
Activity
National Community Pharmacists Association filed 1 comment on this docket between Feb 20, 2026 and Feb 20, 2026. 11 other organizations filed here. The comment window closed 169d ago.
What National Community Pharmacists Association filed (1)
Abstract
OPEN
View on regulations.gov →Co-filers (11)
See everyone who commented →- National Community Pharmacists AssociationTHIS ORG1 filing · confidence 97%
- Sexual Medicine Society of North Americatrade assoc.2 filings · confidence 85%
- Alliance for Pharmacy Compounding and the National Community Pharmacists Associationtrade assoc.1 filing · confidence 85%
- American Association of Clinical Endocrinologytrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- American Urological Associationtrade assoc.1 filing · confidence 85%
- Androgen Societytrade assoc.1 filing · confidence 85%
- Hims & Hers Health Inc.unverified attribution1 filing · confidence 70%
- Taylor Hooton Foundationtrade assoc.1 filing · confidence 85%
- Testosteronology Societytrade assoc.1 filing · confidence 85%
- The Endocrine Societytrade assoc.1 filing · confidence 85%
- You. A Medical Corporationunverified attribution1 filing · confidence 70%